Want to see SG:H02 full AI Analyst Report?
H02 Stock Chart & Stats
S$14.78
-S$0.19(-1.17%)
At close: 4:00 PM EDT
S$14.78
-S$0.19(-1.17%)
Day’s Range― - ―
52-Week RangeS$12.91 - S$18.27
Previous CloseN/A
Volume164.30K
Average Volume (3M)329.99K
Market Cap
S$2.88B
Enterprise ValueS$2.68B
Total Cash (Recent Filing)S$881.34M
Total Debt (Recent Filing)S$52.60M
Price to Earnings (P/E)12.6
Beta0.73
Next Earnings
Feb 19, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.06%
Share Statistics
EPS (TTM)1.04
Shares Outstanding221,368,180
10 Day Avg. Volume218,050
30 Day Avg. Volume329,993
Financial Highlights & Ratios
PEG Ratio0.79
Price to Book (P/B)0.81
Price to Sales (P/S)15.10
P/FCF Ratio12.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.25
Revenue Forecast (FY)S$244.68M
Bulls Say, Bears Say
Bulls Say
Very Low Leverage And Strong Financial FlexibilityThe extremely conservative balance sheet reduces financial risk and preserves flexibility for dividends, investment, or operating needs. Minimal leverage also limits interest burden and refinancing exposure, giving Haw Par resilience if business conditions weaken over the next several quarters.
Strong 2025 Cash GenerationThe sharp improvement in operating and free cash flow provides tangible funding for distributions and reinvestment without relying heavily on borrowing. Free cash flow nearly matching net income in 2025 also supports the quality of the latest earnings and strengthens financial durability.
Established Tiger Balm Brand And Broad DistributionA recognised consumer healthcare brand can support repeat purchases, pricing discipline, and durable shelf presence across multiple markets. Combined with distributor and retail coverage, this gives Haw Par an established route to consumers and a foundation for sustaining its core healthcare business.
Bears Say
2025 Revenue ContractionThe reversal from several years of revenue expansion to a 2025 decline indicates that top-line momentum is not consistently sustained. Continued weakness would reduce operating leverage, constrain reinvestment capacity, and make future earnings more dependent on margins or non-operating income.
Unusually High Net Margins Reduce Earnings VisibilityReported net profits that are unusually high relative to revenue may not represent the recurring earning power of the operating businesses. If non-operating contributions fluctuate, future results could be less predictable and headline earnings may overstate the sustainable contribution from healthcare and leisure.
Historically Uneven Cash ConversionThe weak cash conversion recorded in several earlier years shows that earnings have not always translated consistently into operating cash. Although 2025 improved materially, this history suggests cash generation may remain lumpy and complicate dependable funding of distributions or growth initiatives.
Haw Par News
H02 FAQ
What was Haw Par Corporation Limited’s price range in the past 12 months?
Haw Par Corporation Limited lowest share price was S$12.91 and its highest was S$18.27 in the past 12 months.
What is Haw Par Corporation Limited’s market cap?
Haw Par Corporation Limited’s market cap is S$2.88B.
When is Haw Par Corporation Limited’s upcoming earnings report date?
Haw Par Corporation Limited’s upcoming earnings report date is Feb 19, 2027 which is in 135 days.
How were Haw Par Corporation Limited’s earnings last quarter?
Haw Par Corporation Limited released its earnings results on Aug 14, 2026. The company reported S$0.487 earnings per share for the quarter.
Is Haw Par Corporation Limited overvalued?
According to Wall Street analysts Haw Par Corporation Limited’s price is currently Overvalued.
Does Haw Par Corporation Limited pay dividends?
Haw Par Corporation Limited pays a Semiannually dividend of S$0.2 which represents an annual dividend yield of 3.06%. See more information on Haw Par Corporation Limited dividends here
What is Haw Par Corporation Limited’s EPS estimate?
Haw Par Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Haw Par Corporation Limited have?
Haw Par Corporation Limited has 221,368,180 shares outstanding.
What happened to Haw Par Corporation Limited’s price movement after its last earnings report?
Haw Par Corporation Limited reported an EPS of S$0.487 in its last earnings report. Following the earnings report the stock price went up 0.585%.
Which hedge fund is a major shareholder of Haw Par Corporation Limited?
Currently, no hedge funds are holding shares in SG:H02
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Haw Par Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.35%
12-Months-Change
Fundamentals
Return on Equity
3.06%
Trailing 12-Months
Asset Growth
14.13%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Haw Par Corporation Limited
Established in Singapore in 1969, Haw Par Corporation Limited specializes in the manufacturing, marketing, and global trade of healthcare products, serving markets in Singapore, ASEAN countries, other Asian regions, and beyond. The company's business activities are structured into three main segments: Healthcare, Investments, and Others. Its Healthcare segment primarily produces and distributes topical pain relief solutions, prominently featuring the Tiger Balm and Kwan Loong brands. The Investments segment focuses on acquiring publicly traded securities. Additionally, Haw Par owns and leases out a diverse portfolio of investment properties, comprising 45,324 square meters of commercial and industrial real estate across Singapore and Malaysia. The corporation also offers family and tourist-oriented leisure experiences, notably through oceanariums. Furthermore, it provides leasing services for land, buildings, and office spaces, in addition to offering management support.
Technical Analysis
Raffles Medical Group
―
Thomson Medical Group Ltd.
―
Hyphens Pharma International Ltd.
―
ISEC Healthcare Ltd
―
Medtecs International Corporation Ltd.
―



